Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting
Alkermes will present 11 posters at the American Society of Clinical Psychopharmacology Annual Meeting in Miami, May 26-29, 2026. The presentations cover real-world data for commercial assets LYBALVI and ARISTADA, as well as clinical data for investigational orexin agonists including alixorexton.
Key figures
- Poster count
- 11
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.